Cataract Surgery and Postoperative Care – Part II

Dear Colleagues,

In January 2020, the first volume of the Special Issue “Cataract Surgery and Postoperative Care” was launched (https://www.mdpi.com/journal/jcm/special_issues/Cataract_Postoperative). We received many excellent papers on cataract surgery. Now, we would like to launch the second volume on this topic.

Cataract surgery is one of the most frequently performed surgical procedures in many countries. The surgical procedure itself is considered safe and efficient with good visual outcomes, and the development of modern surgical techniques and technologies has considerably reduced the frequency of complications. Furthermore, these advancements, yielding a precise postoperative refractive result, have raised the patient’s expectations for excellent uncorrected distance visual acuity. Multifocal intraocular lenses (MIOLs) are used more commonly and to a considerable extent for refractive purposes in non-cataractous eyes.

Complications are still a substantial burden because of the sheer number of cataract surgeries performed worldwide each year. Pseudophakic cystoid macular edema (PCME; Irvine–Gass syndrome) is one of the most common causes of visual impairment after cataract surgery. PCME may occur even in the absence of complications and risk factors. Intraoperative complications including capsule rupture, vitreous loss, and iris trauma are associated with a higher risk for PCME. Other risk factors include uveitis, poor glycemic control of diabetes, and various posterior segment diseases. Currently, there is no common definition for PCME; therefore, the incidences vary greatly among previously published studies.

Pre- and postsurgical medical interventions are employed in order to minimize postoperative inflammation and the risk of developing PCME. Other points of interest when comparing different anti-inflammatory drugs have been the speed of visual recovery, drug tolerability, and patient satisfaction to new treatment protocols such as “dropless” cataract surgery. Other interesting aspects involve the quality of life after RLE/MIOLs.

Achieving the best outcomes and preventing later complications requires diligent postoperative care, which also necessitates adequate patient compliance.

Dr. Raimo Tuuminen
Dr. Piotr Kanclerz
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.